On November 14, 2016
Diabetes Drug Side-Effects Lead to FDA Warning
NATIONAL—INVOKANA, a popular Diabetes medication also known as Canagliflozin, is a drug of the gliflozin class or subtype 2 sodium-glucose transport inhibitors used for the treatment of type 2 diabetes. Use of this drug may be linked to an increased risk of Ketoacidosis, Kidney Failure, Heart Attack or Stroke, FDA warns.
The FDA will commonly issue a warning when serious side-effects are noted and reported. Here is a list if brand name drugs that are currently under investigation by the FDA:
- INVOKANA (Invokamet)
- XIGDO XR
Those persons affected may be entitled to monetary compensation. If you or a loved one has suffered the harmful side effects as a result of using INVOKANA, you have the right to hold the manufacturer of that drug responsible for your injuries. Call TRIPP LAW FIRM – Personal Injury Law at (727)398-2900 in Pinellas/Pasco, (352)610-1080 in Hernando/Citrus, and (941)479-0201 in Manatee/Sarasota, for an immediate, confidential case evaluation. There is NO Fee and NO Costs if we do not obtain a Recovery for YOU!
At the TRIPP LAW FIRM, we have the necessary experience to protect you and your family’s legal rights and pursue the appropriate damages. Don’t hesitate to call us. We answer our phones 24/7/365. The injury law team and staff private investigators at the TRIPP LAW FIRM are ready on a moment’s notice.
TOLL FREE: (888) 392-LAWS (5297)
SAFETY ANNOUNCEMENT: FDA Drug Safety Communication: FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR), U.S. Food & Drug Administration (Jun. 14, 2016), available at http://www.fda.gov/Drugs/DrugSafety/ucm505860.htm.